Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection. (Q30374295)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

2

object named as

Divya Goel

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Damini Singh

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Rakesh Bhatnagar

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

27 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

2786-2792

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Brucella as a potential agent of bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Brucellosis and the respiratory system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Comparison of depopulation and S19-RB51 vaccination strategies for control of bovine brucellosis in high prevalence areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Rough vaccines in animal brucellosis: structural and genetic basis and present status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Effect of living Rev. 1 vaccine in producing long-term immunity against Brucella melitensis infection in sheep in Iran

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

The in vitro sensitivity to brucellergen of leucocytes from guinea pigs experimentally infected with Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Solid lipid nanoparticles as a drug delivery system for peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Confrontation between intracellular bacteria and the immune system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Immunity to brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

based on heuristic

inferred from DOI database lookup

Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

based on heuristic

inferred from DOI database lookup

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.030

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2015.04.030

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

release_jd2qlgx6i5ddzo4ng2ksihqiri

1 reference

https://api.fatcat.wiki/v0/release/jd2qlgx6i5ddzo4ng2ksihqiri

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30374295&oldid=1844646205"